Blood collection devices sales will rise through 2036, driven by blood collection tubes at a 34.0% share of the leading product segment in 2026. The market is valued at USD 9.3 billion in 2026 and is forecast to reach USD 17.4 billion by 2036 as diagnostic testing volumes climb.